<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Chem Inf Model</journal-id>
    <journal-id journal-id-type="publisher-id">ci</journal-id>
    <journal-id journal-id-type="coden">jcisd8</journal-id>
    <journal-title-group>
      <journal-title>Journal of Chemical Information and Modeling</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1549-9596</issn>
    <issn pub-type="epub">1549-960X</issn>
    <publisher>
      <publisher-name>American Chemical
Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">5342320</article-id>
    <article-id pub-id-type="doi">10.1021/acs.jcim.6b00686</article-id>
    <article-categories>
      <subj-group>
        <subject>Application Note</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>3D-e-Chem-VM: Structural Cheminformatics Research
Infrastructure in a Freely Available Virtual Machine</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes" id="ath1">
        <name>
          <surname>McGuire</surname>
          <given-names>Ross</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
        <xref rid="notes-1" ref-type="notes">#</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath2">
        <name>
          <surname>Verhoeven</surname>
          <given-names>Stefan</given-names>
        </name>
        <xref rid="cor2" ref-type="other">*</xref>
        <xref rid="aff3" ref-type="aff">§</xref>
        <xref rid="notes-1" ref-type="notes">#</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <name>
          <surname>Vass</surname>
          <given-names>Márton</given-names>
        </name>
        <xref rid="notes-1" ref-type="notes">#</xref>
        <xref rid="aff4" ref-type="aff">∥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <name>
          <surname>Vriend</surname>
          <given-names>Gerrit</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <name>
          <surname>de Esch</surname>
          <given-names>Iwan J. P.</given-names>
        </name>
        <xref rid="aff4" ref-type="aff">∥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath6">
        <name>
          <surname>Lusher</surname>
          <given-names>Scott
J.</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" id="ath7">
        <name>
          <surname>Leurs</surname>
          <given-names>Rob</given-names>
        </name>
        <xref rid="aff4" ref-type="aff">∥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath8">
        <name>
          <surname>Ridder</surname>
          <given-names>Lars</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" id="ath9">
        <name>
          <surname>Kooistra</surname>
          <given-names>Albert J.</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff4" ref-type="aff">∥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath10">
        <name>
          <surname>Ritschel</surname>
          <given-names>Tina</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath11">
        <name>
          <surname>de Graaf</surname>
          <given-names>Chris</given-names>
        </name>
        <xref rid="cor3" ref-type="other">*</xref>
        <xref rid="aff4" ref-type="aff">∥</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Centre
for Molecular and Biomolecular Informatics (CMBI), <institution>Radboudumc</institution>, 6525 GA Nijmegen, <country>The Netherlands</country></aff>
      <aff id="aff2"><label>‡</label><institution>BioAxis
Research</institution>, Pivot Park, 5349 AE Oss, <country>The
Netherlands</country></aff>
      <aff id="aff3"><label>§</label><institution>Netherlands
eScience Center</institution>, 1098 XG Amsterdam, <country>The Netherlands</country></aff>
      <aff id="aff4"><label>∥</label>Division
of Medicinal Chemistry, Faculty of Sciences, Amsterdam Institute for
Molecules, Medicines and Systems (AIMMS), <institution>Vrije Universiteit Amsterdam</institution>, 1081 HZ Amsterdam, <country>The Netherlands</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>E-mail: <email>ross.mcguire@bioaxisresearch.com</email> (R.McG.)</corresp>
      <corresp id="cor2"><label>*</label>E-mail: <email>S.Verhoeven@esciencecenter.nl</email> (S.V.)</corresp>
      <corresp id="cor3"><label>*</label>E-mail: <email>c.de.graaf@vu.nl</email> (C.d.G.).</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>26</day>
      <month>01</month>
      <year>2017</year>
    </pub-date>
    <pub-date pub-type="ppub">
      <day>27</day>
      <month>02</month>
      <year>2017</year>
    </pub-date>
    <volume>57</volume>
    <issue>2</issue>
    <fpage>115</fpage>
    <lpage>121</lpage>
    <history>
      <date date-type="received">
        <day>16</day>
        <month>11</month>
        <year>2016</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Copyright © 2017 American Chemical
Society</copyright-statement>
      <copyright-year>2017</copyright-year>
      <copyright-holder>American Chemical
Society</copyright-holder>
      <license>
        <license-p>This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci-2016-006868_0004" id="ab-tgr1"/>
      </p>
      <p>3D-e-Chem-VM is an open source, freely
available Virtual Machine
(<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://3d-e-chem.github.io/3D-e-Chem-VM/">http://3d-e-chem.github.io/3D-e-Chem-VM/</uri>) that integrates cheminformatics and bioinformatics tools for the
analysis of protein–ligand interaction data. 3D-e-Chem-VM consists
of software libraries, and database and workflow tools that can analyze
and combine small molecule and protein structural information in a
graphical programming environment. New chemical and biological data
analytics tools and workflows have been developed for the efficient
exploitation of structural and pharmacological protein–ligand
interaction data from proteomewide databases (e.g., ChEMBLdb and PDB),
as well as customized information systems focused on, e.g., G protein-coupled
receptors (GPCRdb) and protein kinases (KLIFS). The integrated structural
cheminformatics research infrastructure compiled in the 3D-e-Chem-VM
enables the design of new approaches in virtual ligand screening (Chemdb4VS),
ligand-based metabolism prediction (SyGMa), and structure-based protein
binding site comparison and bioisosteric replacement for ligand design
(KRIPOdb).</p>
    </abstract>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>ci6b00686</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>ci-2016-006868</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>In
the postgenomic era, data generation in the pharmaceutical sciences
has massively accelerated and new analytical eScience approaches are
needed to adequately exploit this new chemical and biological information.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> Open source cheminformatics tools are available to generate, annotate,
and visualize structures of small molecules and calculate chemical
descriptors and fingerprints for their comparison and the identification
of structure–property or structure–activity relationships.<sup><xref ref-type="bibr" rid="ref3">3</xref>−<xref ref-type="bibr" rid="ref12">12</xref></sup> These tools are available in various forms, often as libraries or
extensions to widely used environments such as R,<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> Python,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> or Java.<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> Data analytics platforms such as KNIME<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> allow the combination of bioinformatics and
cheminformatics tools<sup><xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref18">18</xref></sup> and integration of the growing
amount of publically available chemical, structural, and biological
data from ChEMBL,<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> PubChem,<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> BindingDB,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> and
PDB.<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> KNIME has emerged as a widely used
open source data mining tool, and the KNIME repository contains configurable
nodes to perform a wide variety of functions that can be combined
in customizable data analytics workflows.<sup><xref ref-type="bibr" rid="ref16">16</xref>−<xref ref-type="bibr" rid="ref18">18</xref></sup> The standard
KNIME nodes, together with those supplied by the user community,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> allow access to the functionality of several
cheminformatics tools including RDKit,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> CDK,<sup><xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> ChemAxon,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Erlwood,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> Indigo,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> and OpenBabel.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> The EMBL-EBI<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> and
Vernalis nodes,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> provide access to ChEMBL
and PDB, respectively, and the OpenPhacts<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> (ChemBioNavigator,<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> PharmaTrek<sup><xref ref-type="bibr" rid="ref26">26</xref></sup>) nodes allow the mining of yet more heterogeneous
data.</p>
    <p>The majority of the aforementioned KNIME nodes concentrate
on small
molecule cheminformatics. We have developed new cheminformatics and
bioinformatics tools that provide detailed information on the structural
interactions between small molecule ligands and their biological macromolecular
targets (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://3d-e-chem.github.io">http://3d-e-chem.github.io</uri>) and incorporated these tools in an open source Virtual Machine,
3D-e-Chem-VM, that makes use of the KNIME infrastructure. 3D-e-Chem-VM
consists of software libraries, workflow tools, and databases that
allow interoperability of different chemical and biological data formats,
enabling the analysis and integration of small molecule and protein
structural information in the graphical programming environment of
KNIME. The VM facilitates efficient implementation and updating of
installation prerequisites and dependencies. The new cheminformatics
tools, KNIME nodes, and data analytics workflows enable efficient
data mining from established structural (PDB<sup><xref ref-type="bibr" rid="ref22">22</xref></sup>) and bioactivity (ChEMBL<sup><xref ref-type="bibr" rid="ref19">19</xref></sup>) databases
as well as customized G protein-coupled receptor (GPCRdb<sup><xref ref-type="bibr" rid="ref27">27</xref></sup>) and protein kinase (KLIFS<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref></sup>) focused data resources. The cheminformatics toolbox allows the
design of customizable workflows for virtual screening, off-target
prediction, and ligand design, including bioisostere detection based
on protein–ligand interaction pharmacophore features (KRIPO<sup><xref ref-type="bibr" rid="ref30">30</xref></sup>) and consideration of ligand-based metabolite
prediction (SyGMa<sup><xref ref-type="bibr" rid="ref31">31</xref></sup>). The integrated structural
cheminformatics infrastructure enables large-scale structural chemogenomics
studies, where protein–ligand binding interaction and bioactivity
data are considered across multiple ligands and targets.</p>
    <sec id="sec1.1">
      <title>3D-e-Chem-VM</title>
      <p>KNIME, PostgreSQL,<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> and chemistry-aware
open source tools were integrated to
become the backbone of a desktop cheminformatics infrastructure (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00686/suppl_file/ci6b00686_si_001.pdf">Supporting Information</ext-link>, Figure S1). This system
has been augmented by new tools to use structural protein–ligand
interaction data from KRIPO,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> GPCRdb,<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> and KLIFS<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref></sup> databases and has been
made publically available on GitHub (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://3d-e-chem.github.io">http://3d-e-chem.github.io</uri>). The previously reported myChEMBL VM<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> provided a useful template to design the 3D-e-Chem-VM and a local
copy of the ChEMBL database<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> can optionally
be incorporated into the VM (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/3D-e-Chem/3D-e-Chem-VM/wiki/Datasets#chembl">https://github.com/3D-e-Chem/3D-e-Chem-VM/wiki/Datasets#chembl</uri>). The 3D-e-Chem-VM is available in the Vagrant<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> box catalog of HashiCorp called Atlas.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> The Vagrant box is automatically constructed using Packer,<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> which creates a VirtualBox<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> machine image, installs Lubuntu, and finally executes our
Ansible<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> playbooks to install all the
additional software and enhancements (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00686/suppl_file/ci6b00686_si_001.pdf">Supporting Information</ext-link>, Figure S1). To obtain a copy of the 3D-e-Chem-VM
on a local PC, the user installs VirtualBox and Vagrant, then downloads
the Vagrant box, and starts the VM by running two Vagrant commands:
“vagrant init nlesc/3d-e-chem” then “vagrant
up”. New functionalities implemented in later 3D-e-Chem-VM
releases can be installed using the command “sudo vagrant_upgrade”
from a terminal inside the VM. The GPCRdb, KLIFS, KRIPOdb, and SyGMa
KNIME nodes included in the 3D-e-Chem-VM are built and tested automatically
on the continuous integration platform Travis-CI<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> every time a change is pushed to the Github code repository.<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> The KNIME node development procedure<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> to generate a skeleton, write the code, run
tests, and deploy the nodes via the Eclipse User Interface was automated
using Tycho<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> based Eclipse plug-ins. The
3D-e-Chem KNIME nodes are tested for KNIME version compatibility (specified
in the node config file) and if necessary will be adapted to comply
with future KNIME releases. The 3D-e-Chem-VM requires at least 2 GB
RAM memory to run, 16 GB of disk space, and the CPU must have virtualization
support. The 3D-e-Chem tools and workflows are available for use in
any environment as long as the dependencies and prerequisites are
correctly installed and configured. The 3D-e-Chem-VM further facilitates
the use of the 3D-e-Chem tools and other resources (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00686/suppl_file/ci6b00686_si_001.pdf">Supporting Information</ext-link>, Figure S1) by taking care of these
dependencies and prerequisites, including the preconfiguration of
(i) Python<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> and R<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> packages to facilitate the use of KNIME nodes and workflows, (ii)
scripts to set up infrastructures that allow data mining of locally
installed databases like the Postgresql<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> and RDKit<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> Postgresql cartridge to exploit
a local copy of ChEMBLdb,<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> (iii) additional
cheminformatics modeling and visualization software (e.g., PyMOL,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> Camb,<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> and fpocket<sup><xref ref-type="bibr" rid="ref42">42</xref></sup>), and (iv) OpenPHACTS KNIME functionalities<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> and the new GPCRdb, KLIFS, and KRIPO KNIME nodes
to interact with local files and Web servers.</p>
    </sec>
    <sec id="sec1.2">
      <title>GPCRdb Nodes</title>
      <p>GPCRs
are the largest group of signal
transducing membrane proteins and hence one of the most important
target family for drugs that can stimulate, reduce, or block endogenous
GPCR activity. GPCR structural chemogenomic analyses require the integration
of phylogenetic, sequence, and structure similarity and ligand binding
information.<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref45">45</xref></sup> GPCRdb (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://gpcrdb.org">http://gpcrdb.org</uri>, accessed 25 August
2016) is an online repository of the accumulated knowledge on GPCRs
including structure-based annotation of protein sequence alignments
of 18 787 sequences of 421 receptor subtypes and of 3096 species,
analysis of 142 GPCR crystal structures and GPCR-ligand interactions,
and 14 099 mutational data points.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> For the integration of this data in customizable workflows for systematic
structural chemogenomics analyses we have developed seven KNIME nodes
that interface with GPCRdb via a web service client generated with
Swagger Code Generator.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> An example workflow
utilizing these nodes is shown in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>.<list list-type="bullet"><list-item><p>GPCRDB
Protein Families: Extraction of protein family
information, including the protein names and classifications of all
GPCRs in the four-level hierarchy defined by GPCRdb (class, ligand
type, subfamily, subtype).</p></list-item><list-item><p>GPCRDB Protein
Information: Retrieval of source, species,
and sequence data from UniProt identifiers or protein family identifier.</p></list-item><list-item><p>GPCRDB Protein Residues: Retrieval of residues
and numbering
schemes. This node retrieves all residues of the specified protein
with secondary structure annotation, UniProt numbering, and GPCR residue
numbering.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup></p></list-item><list-item><p>GPCRDB Structures of a Protein: Retrieval of experimental
GPCR structures with literature references, PDB codes, and ligands.</p></list-item><list-item><p>GPCRDB Mutations of a Protein: Retrieval
of single point
mutations in GPCRs, including the sequence position, mutation, ligand,
assay type, mutation effect, protein expression information, and publication
reference.</p></list-item><list-item><p>GPCRDB Structure–Ligand
Interactions: Returns
the sequence numbers of amino acid residues interacting with ligands
in the specified PDB entry. The interaction type is annotated in the
output table.</p></list-item><list-item><p>GPCRDB Protein Similarity:
Returns the sequence identity
and similarity of a query receptor versus a set of receptors, based
on the full sequence or a specified set of residues.</p></list-item></list></p>
      <fig id="fig1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>KNIME workflows to exploit cheminformatics and bioinformatics information
on GPCRs (GPCRdb nodes) and protein kinases (KLIFS nodes). In the
GPCRdb workflow, KNIME nodes are used to enable the extraction and
combination of protein information, sequence, alternative numbering
schemes, mutagenesis data, and experimental structures for a selected
receptor from GPCRdb. The lower branch of the workflow returns all
sequence identities and similarities of the TM domain for the selected
receptors and can be used for further structural chemogenomics analyses<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> using, e.g., structural and structure-based
sequence alignments of the ligand binding site residues of crystallized
aminergic receptors (available in the VM as a PyMOL session). In the
KLIFS workflow, KNIME nodes enable the integrated analysis of structural
kinase–ligand interactions from all structures for a specific
kinase in KLIFS (human MAPK in the example). Kinase–ligand
complexes with a specific hydrogen bond interaction pattern between
the ligand and residues in the hinge region of the kinase (stacked
bar chart) are selected for an all-against-all comparison of their
structural kinase–ligand interactions fingerprints (heat map).
The ligands from the selected structures are compared and the ligand
pair with the lowest chemical similarity and a high interaction fingerprint
similarity are retrieved from KLIFS for binding mode comparison. Meta
nodes in the workflows in panels A and B are indicated with a star
(*). The full workflows are provided in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00686/suppl_file/ci6b00686_si_001.pdf">Supporting Information</ext-link>, Figures S2 and S3.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci-2016-006868_0001" id="gr1" position="float"/>
      </fig>
    </sec>
    <sec id="sec1.3">
      <title>KLIFS Nodes</title>
      <p>Protein kinases are important signal pathway
regulators and comprise one of the largest protein families that are
encoded within the human genome. The KLIFS database (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://klifs.vu-compmedchem.nl">http://klifs.vu-compmedchem.nl</uri>, accessed 25 August 2016)<sup><xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref></sup> contains detailed structural
kinase–ligand interaction information derived from 3354 structures
of catalytic domains of human and mouse protein kinases deposited
in the PDB in order to map the structural determinants of kinase–ligand
binding and selectivity. To leverage this information for structural
chemogenomics analyses we have developed nine KNIME nodes that interface
with KLIFS via a web service client generated with Swagger Code Generator.<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> An example workflow of the KLIFS KNIME nodes
is shown in <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>.</p>
      <sec id="sec1.3.1">
        <title>KLIFS Information Nodes</title>
        <p>
          <list list-type="bullet">
            <list-item>
              <p>Kinase ID Mapper: Maps a user-supplied set of kinase
names (names according to Manning et al.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup>), HGNC gene symbols, or UniProt accession codes to a KLIFS kinase
ID. The output also contains all related kinase information present
within KLIFS (see “Kinase Information Retriever”).</p>
            </list-item>
            <list-item>
              <p>Kinase Information Retriever: Returns a
table comprising
the KLIFS kinase ID, kinase name, HGNC symbol, kinase group, kinase
family, kinase class, species, full name, UniProt accession code,
IUPHAR ID, and the amino acid sequence of the pocket based on the
KLIFS pocket definition using a consistent alignment of 85 residues.</p>
            </list-item>
          </list>
        </p>
      </sec>
      <sec id="sec1.3.2">
        <title>KLIFS Interactions Nodes</title>
        <p>
          <list list-type="bullet">
            <list-item>
              <p>Interaction Fingerprint Decomposer:
Decomposes a protein–ligand
interaction fingerprint (IFP)<sup><xref ref-type="bibr" rid="ref49">49</xref></sup> into a
human-readable table with annotated interactions for each structure.
This node can optionally add the sequence number and the KLIFS residue
position<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> for each pocket residue to the
table.</p>
            </list-item>
            <list-item>
              <p>Interaction Fingerprint Retriever:
Retrieval of the
interaction fingerprint of specific kinase-ligand complexes from KLIFS.
The fingerprint has been corrected for gaps/missing residues within
the KLIFS pocket thereby enabling all-against-all comparisons.</p>
            </list-item>
            <list-item>
              <p>Interaction Types Retriever: Retrieves the
different
interaction types for each bit position of the interaction fingerprint
method and can be used in combination with the interaction fingerprint
decomposer to identify which kinase–ligand interactions are
present in a given set of kinase structures.</p>
            </list-item>
          </list>
        </p>
      </sec>
      <sec id="sec1.3.3">
        <title>KLIFS Ligands Nodes</title>
        <list list-type="bullet">
          <list-item>
            <p>Ligands Overview Retriever: Retrieval of ligand IDs,
three-letter PDB-codes, names, molecular structures (SMILES), and
InChIKeys for all ligands from (a specific set of) kinase-ligand complexes
present within KLIFS.</p>
          </list-item>
        </list>
      </sec>
      <sec id="sec1.3.4">
        <title>KLIFS structures nodes</title>
        <p>
          <list list-type="bullet">
            <list-item>
              <p>Structures Overview Retriever:
Retrieves a list of all
corresponding structures within KLIFS based on a user-supplied set
of KLIFS kinase or ligand IDs (e.g., from a specific kinase family).
The node returns the structure ID, kinase name, kinase ID, PDB-code,
and all other structural annotation data within KLIFS (e.g., pocket
sequence, resolution, quality, ligands, DFG conformation, targeted
subpockets, waters).<sup><xref ref-type="bibr" rid="ref29">29</xref></sup></p>
            </list-item>
            <list-item>
              <p>Structures PDB Mapper: Maps a set of PDB-codes to structure
IDs from KLIFS and provides all related structural information from
KLIFS.</p>
            </list-item>
            <list-item>
              <p>Structures Retriever (MOL2): Retrieves
from KLIFS a
set of structures, (optionally the full complex, the protein, the
pocket, or the ligand) in MOL2 format, based on a user-supplied set
of Structure IDs. As output the node provides a table of aligned structures
based on the KLIFS pocket definition.</p>
            </list-item>
          </list>
        </p>
      </sec>
    </sec>
    <sec id="sec1.4">
      <title>KRIPOdb and KRIPO Nodes</title>
      <p>The KRIPOdb includes an SQLite
database with more than 2.3 × 10<sup>11</sup> pairwise ligand
binding site similarity scores based on KRIPO pharmacophore fingerprints<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> of 483 083 subpockets associated with
the substructures (fragments) of small-molecule ligands identified
in the binding sites of all PDB entries released until 29 June 2016.
The full similarity matrix is available as a web service (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://3d-e-chem.vu-compmedchem.nl/kripodb/ui/">http://3d-e-chem.vu-compmedchem.nl/kripodb/ui/</uri>), whereas a similarity matrix calculated between all crystallized
GPCRs and the whole PDB above a similarity threshold of 0.45 (calculated
as a modified Tanimoto similarity score<sup><xref ref-type="bibr" rid="ref50">50</xref></sup>) is included in the 3D-e-Chem-VM as compact HDF5 file. The KRIPO
Python library with a command line interface is provided inside the
VM to extract and manipulate fragment structural data in KRIPOdb.
We have developed the following two KNIME nodes to efficiently extract
and integrate the information in KRIPOdb.<list list-type="bullet"><list-item><p>Similar Fragments: Retrieval of ligand fragments that
share a similar subpocket with the query fragment, based on a specified
similarity matrix (local HDF5 file or web service URL), similarity
threshold, and maximum number of fragment hits.</p></list-item><list-item><p>Fragment Information: Retrieval of the chemical structures
of the fragment, the full ligand, and the associated PDB based on
the fragment identifier.</p></list-item></list></p>
      <p><xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> presents an example KRIPO
KNIME workflow to identify similar ligand
binding sites (for e.g. off-target prediction) and search for bioisosteric
replacements based on ligand binding site similarity.</p>
      <fig id="fig2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>KRIPO binding site similarity
based bioisosteric replacement and
SyGMa metabolite prediction workflows. Ligands in KRIPOdb that share
a chemical (sub)structure with a specified molecule (doxepin in the
example) are identified and defined as query fragment(s). Ligand (fragment)
binding site hits that share pharmacophore fingerprint similarity
with the binding site(s) associated with the query fragment(s) (e.g.,
the doxepin binding site of the histamine H<sub>1</sub> receptor)
are identified and ranked according to Tanimoto similarity score.
The occurrence of protein targets in the top hit list is analyzed.
The pharmacophore overlay underlying the similarity value of an example
hit (histamine methyltransferase, PDB ID: 2aot; available in the VM as a PyMOL session).
The full workflow is provided in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00686/suppl_file/ci6b00686_si_001.pdf">Supporting Information</ext-link> (Figure S4). In the SyGMa workflow Smiles strings
of clozapine and dasatinib are converted into RDKit molecules for
the prediction of metabolites using the SyGMa Metabolites node, filtered
based on a SyGMa_score threshold of 0.1. The two tables are subsections
of the resulting table, showing the top ranked metabolites of clozapine
and dasatinib, consistent with experimental metabolism data.<sup><xref ref-type="bibr" rid="ref51">51</xref>,<xref ref-type="bibr" rid="ref52">52</xref></sup> Meta nodes are indicated with a star (*).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci-2016-006868_0002" id="gr2" position="float"/>
      </fig>
    </sec>
    <sec id="sec1.5">
      <title>SyGMa Node</title>
      <p>For the assessment or prediction of a complete
pharmacological profile, the metabolites of a drug molecule need to
be taken into account. SyGMa is a rule-based method for <bold>sy</bold>stematic <bold>g</bold>eneration of potential <bold>m</bold>et<bold>a</bold>bolites.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> We have developed a
SyGMa KNIME node thin wrapper around the SyGMa<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> Python library that enables straightforward generation
of the structures of possible metabolites of a specified molecule.
The <italic>SyGMa Metabolites</italic> node generates putative metabolites
based on the 2D coordinates of molecules in RDKit format, and the
definition of the number of phase 1 and phase 2 metabolism cycles
in the node dialogue. The SyGMa_metabolite output column contains
the resulting metabolite structures, including the parent, ordered
by decreasing probability score. The generated 2D chemical structures
are aligned to atomic coordinates of the parent, which facilitates
visual inspection of the metabolic modifications. The SyGMa_pathway
column lists the metabolic reaction rules that were applied to result
in the given metabolite structure. The SyGMa_score column lists the
probability score, which can be used to filter the results. <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> shows a simple workflow
to predict the metabolites for the GPCR antagonist clozapine and kinase
inhibitor dasatinib.</p>
    </sec>
    <sec id="sec1.6">
      <title>3D-e-Chem Workflow Application Example 1:
Kinase Interaction
Pattern Analysis</title>
      <p>In the KLIFS workflow (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>) information on all 14 human
MAPK kinases with crystal structure data is retrieved from KLIFS (478
monomers from 312 unique PDB structures). Subsequently, for each MAPK
kinase–ligand complex the interaction fingerprints (IFPs),
describing the interactions between the residues in the binding site
of the enzyme and the ligand, are downloaded. From these IFPs the
H-bond donor and acceptor interaction frequency with the hinge region
of the kinases are summarized in a stacked bar chart. The IFPs are
then filtered to obtain only those kinase–ligand complexes
in which the ligand has an H-bond donor for residue hinge.46 (gatekeeper
+ 1) and an H-bond acceptor for residue hinge.48 (gatekeeper + 3).
In 98 of the 478 monomers (58 unique PDB structures), this interaction
pattern with the hinge region is observed. The interaction pattern
similarity for these monomers is calculated using the Tanimoto coefficient
(Tc) on the IFPs as visualized in a heat map, showing that overall
IFP similarity is relatively low despite their shared hinge interaction
pattern. Finally, this group of monomers is used to identify structures
with a high IFP similarity but low structural similarity of the ligands.
To this end, the molecular structures of the ligands are obtained
and compared to each other using the ECFP-4<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> fingerprint and the Tanimoto coefficient. Subsequently, the IFP
and ligand similarity matrices are combined to select the structure
pair with a high IFP similarity<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> (Tc ≥
0.75) and the lowest chemical similarity (PDB IDs 3pze and 4qp4, ECFP-4 similarity:
0.07, IFP similarity: 0.76). The 3D ligand binding modes are downloaded
from KLIFS and shown in the 3D-viewer MarvinSpace. This workflow can,
among others, be used for scaffold hopping purposes by identifying
ligands with a high IFP similarity, but a relatively low chemical
similarity. For example, the structures with PDB IDs 3gc8 (MAPK11) and 3fl4 (MAPK14) contain
ligands that are chemically different (ECFP-4 similarity: 0.2) but
share similar binding modes (IFP similarity: 0.76), identifying the
pyrazolopyrimidine (3fl4) to dihydroquinazolinone (3gc8) scaffold hop as an interesting design strategy to
obtain kinase inhibitors with similar structural interaction patterns.<sup><xref ref-type="bibr" rid="ref55">55</xref></sup></p>
    </sec>
    <sec id="sec1.7">
      <title>3D-e-Chem Workflow Application Example 2:
GPCR-Kinase Cross-Reactivity
Prediction</title>
      <p>A workflow combining different 3D-e-Chem functionalities
was created to illustrate their integration and applicability for
structural chemogenomics studies across different protein families.
The full GPCR-kinase cross-reactivity prediction workflow for off-target
identification, ligand repurposing, or the discovery of ligands with
a desired GPCR-kinase polypharmacological profile is shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00686/suppl_file/ci6b00686_si_001.pdf">Supporting Information</ext-link> Figure S5. In this workflow
the GPCRdb and KLIFS nodes are used to fetch all experimentally determined
structures of ligand-protein complexes in the two drug target families.
The KRIPO nodes are subsequently used to assess the structure-based
pharmacophore similarity between all GPCR and kinase binding sites,
yielding 1428 similar GPCR-kinase pairs (modified Tanimoto coefficient<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> &gt;0.5). The analysis for example identified
the
similar ergotamine bound serotonin 5-HT<sub>2B</sub> receptor (PDB: 4ib4) and Sorafenib bound
MAPK14 (PDB: 3heg, IC<sub>50</sub> = 57 nM) binding site pair (modified Tc = 0.55),
which is consistent with the recent experimental identification of
Sorafenib as a high affinity 5-HT<sub>2B</sub> ligand (<italic>K</italic><sub>i</sub> = 56 nM).<sup><xref ref-type="bibr" rid="ref56">56</xref></sup></p>
      <p>Combination
of the KRIPO pharmacophore similarity assessment and a systematic
ChEMBL database<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> search indicated for
example that the 5-HT<sub>2B</sub> receptor also shares a similar
binding site and experimentally evaluated ligands with several other
kinases, including CDK8, ABL1, DDR1, FGFR1, KIT, HCK, VGFR2, and B-raf.
The MAPK14 kinase furthermore shares high binding site similarity
and experimentally validated ligands with the adenosine A<sub>2A</sub><sup><xref ref-type="bibr" rid="ref57">57</xref>,<xref ref-type="bibr" rid="ref58">58</xref></sup> and smoothened (SMOR)<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> G protein-coupled receptors, amongst others. The computationally
predicted kinase-GPCR pairs offer opportunities for the rational identification
and design of ligands with well-defined polypharmacological profiles.<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> The kinase-GPCR cross-reactivity workflow can
for example be complemented by the Chemdb4VS workflow for the evaluation
and optimization of virtual screening strategies to identify selective
or multitarget ligands (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). In addition, the SyGMa metabolite predictor node can be
used to enumerate potential metabolites of ligands identified for
drug repurposing or of hits identified in virtual screening (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>).</p>
      <p>The 3D-e-Chem-VM provides
preconfigured starting points that can be easily adapted to construct
flexible structural chemogenomics analysis and drug design workflows
using the 3D-e-Chem structural cheminformatics research tools.</p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Schematic diagram
of possible interactions of the 3D-e-Chem-VM
virtual machine elements: KLIFS and GPCRdb web service connector nodes,
KRIPOdb, KRIPO, and SyGMa nodes, and the Chemdb4VS workflow (full
workflow presented in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00686/suppl_file/ci6b00686_si_001.pdf">Supporting Information</ext-link>, Figure S6) integrated in a GPCR-kinase cross-reactivity prediction
workflow.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci-2016-006868_0003" id="gr3" position="float"/>
      </fig>
    </sec>
  </sec>
</body>
<back>
  <notes id="notes-2" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information
is available free of charge on the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org">ACS Publications website</ext-link> at DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/abs/10.1021/acs.jcim.6b00686">10.1021/acs.jcim.6b00686</ext-link>.<list id="silist" list-type="simple"><list-item><p>Figures presenting
the full versions of the GPCRdb,
KLIFS, KRIPO, SyGMa, Chemdb4VS, and GPCR-kinase cross-reactivity prediction
example KNIME workflows (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jcim.6b00686/suppl_file/ci6b00686_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ci6b00686_si_001.pdf">
        <caption>
          <p>ci6b00686_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="" id="notes-1">
    <title>Author Contributions</title>
    <p><sup>#</sup> R.McG, S.V.,
and M.V. contributed equally.</p>
  </notes>
  <notes notes-type="funding-statement" id="notes-3">
    <p>Netherlands
eScience Center/NWO (3D-e-Chem, grant 027.014.201). M.V., R.L., G.V.,
I.J.P.d.E., A.J.K., and C.d.G. participate in the COST Action CM1207
(GLISTEN). M.V., I.J.P.d.E, R.L., and C.d.G. participate in the GPCR
Consortium (gpcrconsortium.org).</p>
  </notes>
  <notes notes-type="COI-statement" id="NOTES-d133e806-autogenerated">
    <p>The authors declare no
competing financial interest.</p>
  </notes>
  <notes notes-type="" id="NOTES-d133e794-autogenerated">
    <title>Notes</title>
    <p>Downloads and documentation
of the 3D-e-Chem VM, GPCRdb,
KLIFS, KRIPO, SyGMa, and Chemdb4VS KNIME nodes and workflows, as well
as other 3D-e-Chem tools and databases are accessible from <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://3d-e-chem.github.io">http://3d-e-chem.github.io</uri>.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>Vignir Isberg,
Christian Munk, and David Gloriam from University
of Copenhagen for useful discussions on the developments of the GPCRdb
KNIME nodes.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Bajorath</surname><given-names>J.</given-names></name><article-title>Learning from ’big
data’: compounds and
targets</article-title>. <source>Drug Discovery Today</source><year>2014</year>, <volume>19</volume>, <fpage>357</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2014.02.004</pub-id>.<pub-id pub-id-type="pmid">24561327</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Lusher</surname><given-names>S. J.</given-names></name>; <name><surname>McGuire</surname><given-names>R.</given-names></name>; <name><surname>van Schaik</surname><given-names>R. C.</given-names></name>; <name><surname>Nicholson</surname><given-names>C. D.</given-names></name>; <name><surname>de Vlieg</surname><given-names>J.</given-names></name><article-title>Data-driven medicinal chemistry in
the era of big data</article-title>. <source>Drug Discovery Today</source><year>2014</year>, <volume>19</volume>, <fpage>859</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2013.12.004</pub-id>.<pub-id pub-id-type="pmid">24361338</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="weblink" id="cit3">RDKit. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.rdkit.org">http://www.rdkit.org</uri>.</mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Steinbeck</surname><given-names>C. C.</given-names></name>; <name><surname>Han</surname><given-names>Y.</given-names></name>; <name><surname>Kuhn</surname><given-names>S.</given-names></name>; <name><surname>Horlacher</surname><given-names>O.</given-names></name>; <name><surname>Luttmann</surname><given-names>E.</given-names></name>; <name><surname>Willighagen</surname><given-names>E.</given-names></name><article-title>The Chemistry
Development Kit</article-title>. <source>J. Chem. Inf. Comput. Sci.</source><year>2003</year>, <volume>43</volume>, <fpage>493</fpage>–<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1021/ci025584y</pub-id>.<pub-id pub-id-type="pmid">12653513</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="weblink" id="cit5">Jmol. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://jmol.sourceforge.net/">http://jmol.sourceforge.net/</uri>.</mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="weblink" id="cit6">Pymol. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.pymol.org/">https://www.pymol.org/</uri>.</mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="weblink" id="cit7">ChemAxon. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.chemaxon.com/">https://www.chemaxon.com/</uri>.</mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="weblink" id="cit8">Indigo. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://lifescience.opensource.epam.com/indigo/">http://lifescience.opensource.epam.com/indigo/</uri>.</mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>O’Boyle</surname><given-names>N.</given-names></name>; <name><surname>Banck</surname><given-names>M.</given-names></name>; <name><surname>James</surname><given-names>C.</given-names></name>; <name><surname>Morley</surname><given-names>C.</given-names></name>; <name><surname>Vandermeersch</surname><given-names>T.</given-names></name>; <name><surname>Hutchison</surname><given-names>G.</given-names></name><article-title>Open babel: an open chemical toolbox</article-title>. <source>J. Cheminf.</source><year>2011</year>, <volume>3</volume>, <fpage>33</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Beisken</surname><given-names>S.</given-names></name>; <name><surname>Meinl</surname><given-names>T.</given-names></name>; <name><surname>Wiswedel</surname><given-names>B.</given-names></name>; <name><surname>de Figueiredo</surname><given-names>L. F.</given-names></name>; <name><surname>Berthold</surname><given-names>M.</given-names></name>; <name><surname>Steinbeck</surname><given-names>C.</given-names></name><article-title>KNIME-CDK:
Workflow-driven cheminformatics</article-title>. <source>BMC Bioinf.</source><year>2013</year>, <volume>14</volume>, <fpage>257</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-14-257</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Murrell</surname><given-names>D. S.</given-names></name>; <name><surname>Cortes-Ciriano</surname><given-names>I.</given-names></name>; <name><surname>van Westen</surname><given-names>G. J.</given-names></name>; <name><surname>Stott</surname><given-names>I. P.</given-names></name>; <name><surname>Bender</surname><given-names>A.</given-names></name>; <name><surname>Malliavin</surname><given-names>T. E.</given-names></name>; <name><surname>Glen</surname><given-names>R. C.</given-names></name><article-title>Chemically Aware Model Builder (camb):
an R package for property and bioactivity modelling of small molecules</article-title>. <source>J. Cheminf.</source><year>2015</year>, <volume>7</volume>, <fpage>45</fpage><pub-id pub-id-type="doi">10.1186/s13321-015-0086-2</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Sander</surname><given-names>T.</given-names></name>; <name><surname>Freyss</surname><given-names>J.</given-names></name>; <name><surname>von Korff</surname><given-names>M.</given-names></name>; <name><surname>Rufener</surname><given-names>C.</given-names></name><article-title>Datawarrior: An Open-Source
Program for Chemistry Aware Data Visualization and Analysis</article-title>. <source>J. Chem. Inf. Model.</source><year>2015</year>, <volume>55</volume>, <fpage>460</fpage>–<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1021/ci500588j</pub-id>.<pub-id pub-id-type="pmid">25558886</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="book" id="cit13"><collab>R Core
Team. R</collab>: <source>A language and environment for statistical
computing</source>; <publisher-name>R Foundation for Statistical Computing</publisher-name>, <publisher-loc>Vienna, Austria</publisher-loc>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.R-project.org/">http://www.R-project.org/</uri>.</mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="weblink" id="cit14">Python. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.python.org">http://www.python.org</uri>.</mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="weblink" id="cit15">Java. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.oracle.com/java/index.html">https://www.oracle.com/java/index.html</uri>.</mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="book" id="cit16"><person-group person-group-type="allauthors"><name><surname>Berthold</surname><given-names>M. R.</given-names></name>; <name><surname>Cebron</surname><given-names>N.</given-names></name>; <name><surname>Dill</surname><given-names>F.</given-names></name>; <name><surname>Gabriel</surname><given-names>T. R.</given-names></name>; <name><surname>Kötter</surname><given-names>T.</given-names></name>; <name><surname>Meinl</surname><given-names>T.</given-names></name>; <name><surname>Ohl</surname><given-names>P.</given-names></name>; <name><surname>Sieb</surname><given-names>C.</given-names></name>; <name><surname>Thiel</surname><given-names>K.</given-names></name>; <name><surname>Wiswedel</surname><given-names>B.</given-names></name></person-group><article-title>KNIME:
The Konstanz Information Miner</article-title>. In <source>Data Analysis,
Machine Learning and Applications</source>; <publisher-name>Springer
Berlin Heidelberg</publisher-name>, <year>2007</year>; pp <fpage>319</fpage>–<lpage>326</lpage>.</mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Mazanetz</surname><given-names>M. P.</given-names></name>; <name><surname>Marmon</surname><given-names>R. J.</given-names></name>; <name><surname>Reisser</surname><given-names>C. B.</given-names></name>; <name><surname>Morao</surname><given-names>I.</given-names></name><article-title>Drug Discovery Applications
for KNIME: An Open Source Data Mining Platform</article-title>. <source>Curr. Top. Med. Chem.</source><year>2012</year>, <volume>12</volume>, <fpage>1965</fpage>–<lpage>1979</lpage>. <pub-id pub-id-type="doi">10.2174/156802612804910331</pub-id>.<pub-id pub-id-type="pmid">23110532</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="weblink" id="cit18">KNIME
Cheminformatics Extensions. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://tech.knime.org/cheminformatics-extensions">https://tech.knime.org/cheminformatics-extensions</uri>.</mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Bento</surname><given-names>A. P.</given-names></name>; <name><surname>Gaulton</surname><given-names>A.</given-names></name>; <name><surname>Hersey</surname><given-names>A.</given-names></name>; <name><surname>Bellis</surname><given-names>L. J.</given-names></name>; <name><surname>Chambers</surname><given-names>J.</given-names></name>; <name><surname>Davies</surname><given-names>M.</given-names></name>; <name><surname>Krüger</surname><given-names>F. A.</given-names></name>; <name><surname>Light</surname><given-names>Y.</given-names></name>; <name><surname>Mak</surname><given-names>L.</given-names></name>; <name><surname>McGlinchey</surname><given-names>S.</given-names></name>; <name><surname>Nowotka</surname><given-names>M.</given-names></name>; <name><surname>Papadatos</surname><given-names>G.</given-names></name>; <name><surname>Santos</surname><given-names>R.</given-names></name>; <name><surname>Overington</surname><given-names>J. P.</given-names></name><article-title>The ChEMBL
Bioactivity Database:
An Update</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>, <volume>42</volume>, <fpage>D1083</fpage>–<lpage>1090</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt1031</pub-id>.<pub-id pub-id-type="pmid">24214965</pub-id></mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="journal" id="cit20"><name><surname>Kim</surname><given-names>S.</given-names></name>; <name><surname>Thiessen</surname><given-names>P. A.</given-names></name>; <name><surname>Bolton</surname><given-names>E. E.</given-names></name>; <name><surname>Chen</surname><given-names>J.</given-names></name>; <name><surname>Fu</surname><given-names>G.</given-names></name>; <name><surname>Gindulyte</surname><given-names>A.</given-names></name>; <name><surname>Han</surname><given-names>L.</given-names></name>; <name><surname>He</surname><given-names>J.</given-names></name>; <name><surname>He</surname><given-names>S.</given-names></name>; <name><surname>Shoemaker</surname><given-names>B. A.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Yu</surname><given-names>B.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name>; <name><surname>Bryant</surname><given-names>S. H.</given-names></name><article-title>PubChem
Substance and Compound databases</article-title>. <source>Nucleic Acids
Res.</source><year>2016</year>, <volume>44</volume>, <fpage>D1202</fpage>–<lpage>1213</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv951</pub-id>.<pub-id pub-id-type="pmid">26400175</pub-id></mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Liu</surname><given-names>T.</given-names></name>; <name><surname>Lin</surname><given-names>Y.</given-names></name>; <name><surname>Wen</surname><given-names>X.</given-names></name>; <name><surname>Jorissen</surname><given-names>R. N.</given-names></name>; <name><surname>Gilson</surname><given-names>M. K.</given-names></name><article-title>BindingDB: a web-accessible
database of experimentally determined protein–ligand binding
affinities</article-title>. <source>Nucleic Acids Res.</source><year>2007</year>, <volume>35</volume>, <fpage>D198</fpage>–<lpage>D201</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkl999</pub-id>.<pub-id pub-id-type="pmid">17145705</pub-id></mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Berman</surname><given-names>H. M.</given-names></name>; <name><surname>W</surname><given-names>J.</given-names></name>; <name><surname>Feng</surname><given-names>Z.</given-names></name>; <name><surname>Gilliland</surname><given-names>G.</given-names></name>; <name><surname>Bhat</surname><given-names>T. N.</given-names></name>; <name><surname>Weissig</surname><given-names>H.</given-names></name>; <name><surname>Shindyalov</surname><given-names>I. N.</given-names></name>; <name><surname>Bourne</surname><given-names>P. E.</given-names></name><article-title>The Protein Data Bank</article-title>. <source>Nucleic
Acids Res.</source><year>2000</year>, <volume>28</volume>, <fpage>235</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id>.<pub-id pub-id-type="pmid">10592235</pub-id></mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Papadatos</surname><given-names>G.</given-names></name>; <name><surname>van Westen</surname><given-names>G. J.</given-names></name>; <name><surname>Croset</surname><given-names>S.</given-names></name>; <name><surname>Santos</surname><given-names>R.</given-names></name>; <name><surname>Trubian</surname><given-names>S.</given-names></name>; <name><surname>Overington</surname><given-names>J. P.</given-names></name><article-title>A document classifier for medicinal chemistry publications
trained on the ChEMBL corpus</article-title>. <source>J. Cheminf.</source><year>2014</year>, <volume>6</volume>, <fpage>40</fpage><pub-id pub-id-type="doi">10.1186/s13321-014-0040-8</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="journal" id="cit24"><name><surname>Williams</surname><given-names>A. J.</given-names></name>; <name><surname>Harland</surname><given-names>L.</given-names></name>; <name><surname>Groth</surname><given-names>P.</given-names></name>; <name><surname>Pettifer</surname><given-names>S.</given-names></name>; <name><surname>Chichester</surname><given-names>C.</given-names></name>; <name><surname>Willighagen</surname><given-names>E. L.</given-names></name>; <name><surname>Evelo</surname><given-names>C. T.</given-names></name>; <name><surname>Blomberg</surname><given-names>N.</given-names></name>; <name><surname>Ecker</surname><given-names>G.</given-names></name>; <name><surname>Goble</surname><given-names>C.</given-names></name>; <name><surname>Mons</surname><given-names>B.</given-names></name><article-title>Open PHACTS: semantic interoperability
for drug discovery</article-title>. <source>Drug Discovery Today</source><year>2012</year>, <volume>17</volume>, <fpage>1188</fpage>–<lpage>1198</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2012.05.016</pub-id>.<pub-id pub-id-type="pmid">22683805</pub-id></mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Stierand</surname><given-names>K.</given-names></name>; <name><surname>Harder</surname><given-names>T.</given-names></name>; <name><surname>Marek</surname><given-names>T.</given-names></name>; <name><surname>Hilbig</surname><given-names>M.</given-names></name>; <name><surname>Lemmen</surname><given-names>C.</given-names></name>; <name><surname>Rarey</surname><given-names>M.</given-names></name><article-title>The Internet as Scientific
Knowledge Base: Navigating the Chem-Bio
Space</article-title>. <source>Mol. Inf.</source><year>2012</year>, <volume>31</volume>, <fpage>543</fpage>–<lpage>546</lpage>. <pub-id pub-id-type="doi">10.1002/minf.201200037</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Carrascosa</surname><given-names>M. C.</given-names></name>; <name><surname>Massaguer</surname><given-names>O. L.</given-names></name>; <name><surname>Mestres</surname><given-names>J.</given-names></name><article-title>PharmaTrek: A Semantic Web Explorer
for Open Innovation in Multitarget Drug Discovery</article-title>. <source>Mol. Inf.</source><year>2012</year>, <volume>31</volume>, <fpage>537</fpage>–<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1002/minf.201200070</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Isberg</surname><given-names>V.</given-names></name>; <name><surname>Mordalski</surname><given-names>S.</given-names></name>; <name><surname>Munk</surname><given-names>C.</given-names></name>; <name><surname>Rataj</surname><given-names>K.</given-names></name>; <name><surname>Harpsøe</surname><given-names>K.</given-names></name>; <name><surname>Hauser</surname><given-names>A. S.</given-names></name>; <name><surname>Vroling</surname><given-names>B.</given-names></name>; <name><surname>Bojarski</surname><given-names>A. J.</given-names></name>; <name><surname>Vriend</surname><given-names>G.</given-names></name>; <name><surname>Gloriam</surname><given-names>D. E.</given-names></name><article-title>GPCRDB: an information system for G protein-coupled
receptors</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>, <volume>44</volume>, <fpage>D356</fpage>–<lpage>D364</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1178</pub-id>.<pub-id pub-id-type="pmid">26582914</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>van
Linden</surname><given-names>O. P.</given-names></name>; <name><surname>Kooistra</surname><given-names>A. J.</given-names></name>; <name><surname>Leurs</surname><given-names>R.</given-names></name>; <name><surname>de Esch</surname><given-names>I. J.</given-names></name>; <name><surname>de Graaf</surname><given-names>C.</given-names></name><article-title>KLIFS: a knowledge-based structural database to navigate
kinase–ligand interaction space</article-title>. <source>J. Med.
Chem.</source><year>2014</year>, <volume>57</volume>, <fpage>249</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1021/jm400378w</pub-id>.<pub-id pub-id-type="pmid">23941661</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Kooistra</surname><given-names>A.
J.</given-names></name>; <name><surname>Kanev</surname><given-names>G. K.</given-names></name>; <name><surname>van Linden</surname><given-names>O. P.</given-names></name>; <name><surname>Leurs</surname><given-names>R.</given-names></name>; <name><surname>de Esch</surname><given-names>I. J.</given-names></name>; <name><surname>de Graaf</surname><given-names>C.</given-names></name><article-title>KLIFS: a structural
kinase-ligand interaction database</article-title>. <source>Nucleic
Acids Res.</source><year>2016</year>, <volume>44</volume>, <fpage>D365</fpage>–<lpage>371</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1082</pub-id>.<pub-id pub-id-type="pmid">26496949</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Wood</surname><given-names>D. J.</given-names></name>; <name><surname>de Vlieg</surname><given-names>J.</given-names></name>; <name><surname>Wagener</surname><given-names>M.</given-names></name>; <name><surname>Ritschel</surname><given-names>T.</given-names></name><article-title>Pharmacophore fingerprint-based
approach to binding site subpocket similarity and its application
to bioisostere replacement</article-title>. <source>J. Chem. Inf. Model.</source><year>2012</year>, <volume>52</volume>, <fpage>2031</fpage>–<lpage>2043</lpage>. <pub-id pub-id-type="doi">10.1021/ci3000776</pub-id>.<pub-id pub-id-type="pmid">22830492</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Ridder</surname><given-names>L.</given-names></name>; <name><surname>Wagener</surname><given-names>M.</given-names></name><article-title>SyGMa: combining expert
knowledge and empirical scoring
in the prediction of metabolites</article-title>. <source>ChemMedChem</source><year>2008</year>, <volume>3</volume>, <fpage>821</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.200700312</pub-id>.<pub-id pub-id-type="pmid">18311745</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="weblink" id="cit32">Postgresql. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.postgresql.org/">https://www.postgresql.org/</uri>.</mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>Ochoa</surname><given-names>R.</given-names></name>; <name><surname>Davies</surname><given-names>M.</given-names></name>; <name><surname>Papadatos</surname><given-names>G.</given-names></name>; <name><surname>Atkinson</surname><given-names>F.</given-names></name>; <name><surname>Overington</surname><given-names>J. P.</given-names></name><article-title>myChEMBL:
a virtual machine implementation of open data and cheminformatics
tools</article-title>. <source>Bioinformatics</source><year>2014</year>, <volume>30</volume>, <fpage>298</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt666</pub-id>.<pub-id pub-id-type="pmid">24262214</pub-id></mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="weblink" id="cit34"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.vagrantup.com/">https://www.vagrantup.com/</uri>.</mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="weblink" id="cit35"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://atlas.hashicorp.com/boxes/search">https://atlas.hashicorp.com/boxes/search</uri>.</mixed-citation>
    </ref>
    <ref id="ref36">
      <mixed-citation publication-type="weblink" id="cit36"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.packer.io/">https://www.packer.io/</uri>.</mixed-citation>
    </ref>
    <ref id="ref37">
      <mixed-citation publication-type="weblink" id="cit37"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.virtualbox.org/">https://www.virtualbox.org/</uri>.</mixed-citation>
    </ref>
    <ref id="ref38">
      <mixed-citation publication-type="weblink" id="cit38"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ansible.com">http://www.ansible.com</uri>.</mixed-citation>
    </ref>
    <ref id="ref39">
      <mixed-citation publication-type="weblink" id="cit39">Travis-CI. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://travis-ci.org/">https://travis-ci.org/</uri>.</mixed-citation>
    </ref>
    <ref id="ref40">
      <mixed-citation publication-type="weblink" id="cit40"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.eclipse.org/tycho/">http://www.eclipse.org/tycho/</uri>.</mixed-citation>
    </ref>
    <ref id="ref41">
      <mixed-citation publication-type="weblink" id="cit41">KNIME
Developer Guide. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://tech.knime.org/developer-guide">https://tech.knime.org/developer-guide</uri>.</mixed-citation>
    </ref>
    <ref id="ref42">
      <mixed-citation publication-type="journal" id="cit42"><name><surname>Le
Guilloux</surname><given-names>V.</given-names></name>; <name><surname>Schmidtke</surname><given-names>P.</given-names></name>; <name><surname>Tuffery</surname><given-names>P.</given-names></name><article-title>Fpocket: an open source
platform for ligand pocket detection</article-title>. <source>BMC Bioinf.</source><year>2009</year>, <volume>10</volume>, <fpage>168</fpage><pub-id pub-id-type="doi">10.1186/1471-2105-10-168</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref43">
      <mixed-citation publication-type="weblink" id="cit43">OPS-KNIME. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/openphacts/OPS-Knime">https://github.com/openphacts/OPS-Knime</uri>.</mixed-citation>
    </ref>
    <ref id="ref44">
      <mixed-citation publication-type="journal" id="cit44"><name><surname>Kooistra</surname><given-names>A. J.</given-names></name>; <name><surname>Kuhne</surname><given-names>S.</given-names></name>; <name><surname>de Esch</surname><given-names>I. J.</given-names></name>; <name><surname>Leurs</surname><given-names>R.</given-names></name>; <name><surname>de Graaf</surname><given-names>C.</given-names></name><article-title>A structural
chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor
ligand design</article-title>. <source>Br. J. Pharmacol.</source><year>2013</year>, <volume>170</volume>, <fpage>101</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12248</pub-id>.<pub-id pub-id-type="pmid">23713847</pub-id></mixed-citation>
    </ref>
    <ref id="ref45">
      <mixed-citation publication-type="journal" id="cit45"><name><surname>Vass</surname><given-names>M.</given-names></name>; <name><surname>Kooistra</surname><given-names>A. J.</given-names></name>; <name><surname>Ritschel</surname><given-names>T.</given-names></name>; <name><surname>Leurs</surname><given-names>R.</given-names></name>; <name><surname>de Esch</surname><given-names>I. J.</given-names></name>; <name><surname>de Graaf</surname><given-names>C.</given-names></name><article-title>Molecular interaction
fingerprint approaches for GPCR
drug discovery</article-title>. <source>Curr. Opin. Pharmacol.</source><year>2016</year>, <volume>30</volume>, <fpage>59</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2016.07.007</pub-id>.<pub-id pub-id-type="pmid">27479316</pub-id></mixed-citation>
    </ref>
    <ref id="ref46">
      <mixed-citation publication-type="weblink" id="cit46"><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://swagger.io/swagger-codegen">http://swagger.io/swagger-codegen</uri>.</mixed-citation>
    </ref>
    <ref id="ref47">
      <mixed-citation publication-type="journal" id="cit47"><name><surname>Isberg</surname><given-names>V.</given-names></name>; <name><surname>de Graaf</surname><given-names>C.</given-names></name>; <name><surname>Bortolato</surname><given-names>A.</given-names></name>; <name><surname>Cherezov</surname><given-names>V.</given-names></name>; <name><surname>Katritch</surname><given-names>V.</given-names></name>; <name><surname>Marshall</surname><given-names>F. H.</given-names></name>; <name><surname>Mordalski</surname><given-names>S.</given-names></name>; <name><surname>Pin</surname><given-names>J. P.</given-names></name>; <name><surname>Stevens</surname><given-names>R. C.</given-names></name>; <name><surname>Vriend</surname><given-names>G.</given-names></name>; <name><surname>Gloriam</surname><given-names>D. E.</given-names></name><article-title>Generic
GPCR residue numbers - aligning
topology maps while minding the gaps</article-title>. <source>Trends
Pharmacol. Sci.</source><year>2015</year>, <volume>36</volume>, <fpage>22</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2014.11.001</pub-id>.<pub-id pub-id-type="pmid">25541108</pub-id></mixed-citation>
    </ref>
    <ref id="ref48">
      <mixed-citation publication-type="journal" id="cit48"><name><surname>Manning</surname><given-names>G.</given-names></name>; <name><surname>Whyte</surname><given-names>D. B.</given-names></name>; <name><surname>Martinez</surname><given-names>R.</given-names></name>; <name><surname>Hunter</surname><given-names>T.</given-names></name>; <name><surname>Sudarsanam</surname><given-names>S.</given-names></name><article-title>The protein
kinase complement of the human genome</article-title>. <source>Science</source><year>2002</year>, <volume>298</volume>, <fpage>1912</fpage>–<lpage>1934</lpage>. <pub-id pub-id-type="doi">10.1126/science.1075762</pub-id>.<pub-id pub-id-type="pmid">12471243</pub-id></mixed-citation>
    </ref>
    <ref id="ref49">
      <mixed-citation publication-type="journal" id="cit49"><name><surname>Marcou</surname><given-names>G.</given-names></name>; <name><surname>Rognan</surname><given-names>D.</given-names></name><article-title>Optimizing fragment
and scaffold docking by use of
molecular interaction fingerprints</article-title>. <source>J. Chem.
Inf. Model.</source><year>2007</year>, <volume>47</volume>, <fpage>195</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1021/ci600342e</pub-id>.<pub-id pub-id-type="pmid">17238265</pub-id></mixed-citation>
    </ref>
    <ref id="ref50">
      <mixed-citation publication-type="journal" id="cit50"><name><surname>Fligner</surname><given-names>M.
A.</given-names></name>; <name><surname>Verducci</surname><given-names>J. S.</given-names></name>; <name><surname>Blower</surname><given-names>P. E.</given-names></name><article-title>A modification of the Jaccard–Tanimoto
similarity index for diverse selection of chemical compounds using
binary strings</article-title>. <source>Technometrics</source><year>2002</year>, <volume>44</volume>, <fpage>110</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1198/004017002317375064</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref51">
      <mixed-citation publication-type="journal" id="cit51"><name><surname>Nijmeijer</surname><given-names>S.</given-names></name>; <name><surname>Vischer</surname><given-names>H. F.</given-names></name>; <name><surname>Rudebeck</surname><given-names>A. F.</given-names></name>; <name><surname>Fleurbaaij</surname><given-names>F.</given-names></name>; <name><surname>Falck</surname><given-names>D.</given-names></name>; <name><surname>Leurs</surname><given-names>R.</given-names></name>; <name><surname>Niessen</surname><given-names>W. M.</given-names></name>; <name><surname>Kool</surname><given-names>J.</given-names></name><article-title>Development
of a profiling strategy for metabolic mixtures by combining chromatography
and mass spectrometry with cell-based GPCR signaling</article-title>. <source>J. Biomol. Screening</source><year>2012</year>, <volume>17</volume>, <fpage>1329</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1177/1087057112451922</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref52">
      <mixed-citation publication-type="journal" id="cit52"><name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Christopher</surname><given-names>L. J.</given-names></name>; <name><surname>Cui</surname><given-names>D.</given-names></name>; <name><surname>Li</surname><given-names>W.</given-names></name>; <name><surname>Iyer</surname><given-names>R.</given-names></name>; <name><surname>Humphreys</surname><given-names>W. G.</given-names></name>; <name><surname>Zhang</surname><given-names>D.</given-names></name><article-title>Identification of the
human enzymes
involved in the oxidative metabolism of dasatinib: an effective approach
for determining metabolite formation kinetics</article-title>. <source>Drug Metab. Dispos.</source><year>2008</year>, <volume>36</volume>, <fpage>1828</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.107.020255</pub-id>.<pub-id pub-id-type="pmid">18556438</pub-id></mixed-citation>
    </ref>
    <ref id="ref53">
      <mixed-citation publication-type="journal" id="cit53"><name><surname>Rogers</surname><given-names>D.</given-names></name>; <name><surname>Hahn</surname><given-names>M.</given-names></name><article-title>Extended-connectivity fingerprints</article-title>. <source>J. Chem.
Inf. Model.</source><year>2010</year>, <volume>50</volume>, <fpage>742</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1021/ci100050t</pub-id>.<pub-id pub-id-type="pmid">20426451</pub-id></mixed-citation>
    </ref>
    <ref id="ref54">
      <mixed-citation publication-type="journal" id="cit54"><name><surname>Kooistra</surname><given-names>A.
J.</given-names></name>; <name><surname>Vischer</surname><given-names>H. F.</given-names></name>; <name><surname>McNaught-Flores</surname><given-names>D.</given-names></name>; <name><surname>Leurs</surname><given-names>R.</given-names></name>; <name><surname>de Esch</surname><given-names>I. J.</given-names></name>; <name><surname>de Graaf</surname><given-names>C.</given-names></name><article-title>Function-specific
virtual screening for GPCR ligands
using a combined scoring method</article-title>. <source>Sci. Rep.</source><year>2016</year>, <volume>6</volume>, <fpage>28288</fpage><pub-id pub-id-type="doi">10.1038/srep28288</pub-id>.<pub-id pub-id-type="pmid">27339552</pub-id></mixed-citation>
    </ref>
    <ref id="ref55">
      <mixed-citation publication-type="journal" id="cit55"><name><surname>Astolfi</surname><given-names>A.</given-names></name>; <name><surname>Iraci</surname><given-names>N.</given-names></name>; <name><surname>Manfroni</surname><given-names>G.</given-names></name>; <name><surname>Barreca</surname><given-names>M. L.</given-names></name>; <name><surname>Cecchetti</surname><given-names>V.</given-names></name><article-title>A Comprehensive
Structural Overview of p38alpha MAPK in Complex with Type I Inhibitors</article-title>. <source>ChemMedChem</source><year>2015</year>, <volume>10</volume>, <fpage>957</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.201500030</pub-id>.<pub-id pub-id-type="pmid">26012502</pub-id></mixed-citation>
    </ref>
    <ref id="ref56">
      <mixed-citation publication-type="journal" id="cit56"><name><surname>Lin</surname><given-names>X.</given-names></name>; <name><surname>Huang</surname><given-names>X. P.</given-names></name>; <name><surname>Chen</surname><given-names>G.</given-names></name>; <name><surname>Whaley</surname><given-names>R.</given-names></name>; <name><surname>Peng</surname><given-names>S.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>G.</given-names></name>; <name><surname>Wang</surname><given-names>S. X.</given-names></name>; <name><surname>Wang</surname><given-names>S.</given-names></name>; <name><surname>Roth</surname><given-names>B. L.</given-names></name>; <name><surname>Huang</surname><given-names>N.</given-names></name><article-title>Life beyond kinases: structure-based
discovery of sorafenib as nanomolar antagonist of 5-HT receptors</article-title>. <source>J. Med. Chem.</source><year>2012</year>, <volume>55</volume>, <fpage>5749</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1021/jm300338m</pub-id>.<pub-id pub-id-type="pmid">22694093</pub-id></mixed-citation>
    </ref>
    <ref id="ref57">
      <note>
        <p>DRUGMATRIX: Adenosine A2A radioligand binding
assay (ligand: AB-MECA) CHEMBL1909214.</p>
      </note>
    </ref>
    <ref id="ref58">
      <mixed-citation publication-type="journal" id="cit58"><name><surname>Dombroski</surname><given-names>M. A.</given-names></name>; <name><surname>Letavic</surname><given-names>M. A.</given-names></name>; <name><surname>McClure</surname><given-names>K. F.</given-names></name>; <name><surname>Barberia</surname><given-names>J. T.</given-names></name>; <name><surname>Carty</surname><given-names>T. J.</given-names></name>; <name><surname>Cortina</surname><given-names>S. R.</given-names></name>; <name><surname>Csiki</surname><given-names>C.</given-names></name>; <name><surname>Dipesa</surname><given-names>A. J.</given-names></name>; <name><surname>Elliott</surname><given-names>N. C.</given-names></name>; <name><surname>Gabel</surname><given-names>C. A.</given-names></name>; <name><surname>Jordan</surname><given-names>C. K.</given-names></name>; <name><surname>Labasi</surname><given-names>J. M.</given-names></name>; <name><surname>Martin</surname><given-names>W. H.</given-names></name>; <name><surname>Peese</surname><given-names>K. M.</given-names></name>; <name><surname>Stock</surname><given-names>I. A.</given-names></name>; <name><surname>Svensson</surname><given-names>L.</given-names></name>; <name><surname>Sweeney</surname><given-names>F. J.</given-names></name>; <name><surname>Yu</surname><given-names>C. H.</given-names></name><article-title>Benzimidazolone p38 inhibitors</article-title>. <source>Bioorg. Med.
Chem. Lett.</source><year>2004</year>, <volume>14</volume>, <fpage>919</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2003.12.023</pub-id>.<pub-id pub-id-type="pmid">15012994</pub-id></mixed-citation>
    </ref>
    <ref id="ref59">
      <mixed-citation publication-type="journal" id="cit59"><name><surname>Yang</surname><given-names>B.</given-names></name>; <name><surname>Hird</surname><given-names>A. W.</given-names></name>; <name><surname>Russell</surname><given-names>D. J.</given-names></name>; <name><surname>Fauber</surname><given-names>B. P.</given-names></name>; <name><surname>Dakin</surname><given-names>L. A.</given-names></name>; <name><surname>Zheng</surname><given-names>X.</given-names></name>; <name><surname>Su</surname><given-names>Q.</given-names></name>; <name><surname>Godin</surname><given-names>R.</given-names></name>; <name><surname>Brassil</surname><given-names>P.</given-names></name>; <name><surname>Devereaux</surname><given-names>E.</given-names></name>; <name><surname>Janetka</surname><given-names>J. W.</given-names></name><article-title>Discovery of novel hedgehog antagonists
from cell-based screening: Isosteric modification of p38 bisamides
as potent inhibitors of SMO</article-title>. <source>Bioorg. Med. Chem.
Lett.</source><year>2012</year>, <volume>22</volume>, <fpage>4907</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2012.04.104</pub-id>.<pub-id pub-id-type="pmid">22704236</pub-id></mixed-citation>
    </ref>
    <ref id="ref60">
      <mixed-citation publication-type="journal" id="cit60"><name><surname>Peters</surname><given-names>J. U.</given-names></name><article-title>Polypharmacology
- foe or friend?</article-title>. <source>J. Med. Chem.</source><year>2013</year>, <volume>56</volume>, <fpage>8955</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1021/jm400856t</pub-id>.<pub-id pub-id-type="pmid">23919353</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
